The metabolism of drugs has been shown to be markedly influenced by various factors such as age, sex, strain, species, stress, hormones, general nutritional status, as well as by vitamins (1, 2) . Studies so far done with respect to vitamins showed that ascorbic acid, riboflavin and a-tocopherol play a role in the drug-metabolizing systems. Thus, investigations by several workers demon strated that ascorbic acid deficiency results in a decrease in the metabolism of a variety of pharmacological agents (2) and steroids (3) . Ascorbic acid deficiency also decreased the quantities of hepatic microsomal electron transport components which are involved in the metabolism of drugs and ascorbic acid supplements increased the quantities of such components and overall drug metabolism activities (4) . Riboflavin deficiency produced in adult rats was also found to cause a significant decrease in certain drug me tabolism activities (5) . This diminished drug metabolism activity in riboflavin deficiency was also found to be accompanied by a decrease in the quantity of microsomal electron transport components (5 Tables  2 and 3  demonstrate that the phenylbutazone oxidase activity of both liver and kidney decreased significantly in deoxypyridoxine-treated rats that received either the 18% or 8% casein diet. The aminopyrine N-demethylase activity of both liver and kidney was also found to be diminished in deoxypyridoxine-treated rats, whether they received the 18% or 8% casein diet. However, the percentage decrease in the activity of these enzymes in deoxypyridoxine-treated rats was found to be more when the animals were fed on an 8% casein diet. The NADPH oxidase activity of neither liver nor kidney was affected in deoxypyridoxine-treated rats whether they were fed on an 18;% or 8% casein diet. activities of drugs and foreign compounds (26). This is due in part to altered rates of metabolism (26-28). It was further demonstrated that the decreased metabolism of frugs and foreign compounds in protein deficiency is caused mostly by a reduction in the activities of specific drug metabolizing enzymes (26--30). There is also increasing evidence that the activities of microsomal drug-metabolizing enzymes are affected by certain vitamins such as ascorbic acid, riboflavin and a-tocopherol (4). In ascorbic acid deficiency, it was found that there is a decrease in the quantity of hepatic microsomal electron transport components such as cytochrome P-450 and NADPH cytochrome reductase, as well as decreases in a variety of drug enzyme reactions such as N-demethylation, 0-demethylation and steroid hydroxylation (4, 31) . It was also noted that prolonged riboflavin deficiency caused a significant decrease in drug me tabolism activities with substrates such as aniline, acetanilide, aminopyrine and ethyl morphine (5) . With riboflavin deficiency, there were also substantial decreases in microsomal electron transport components (4, 5) .
In the present investigation, pyridoxine deficiency caused by ingestion of deoxy pyridoxine resulted in diminished activities of phEnylbutazone oxidase and aminopyrine N demethylase of both liver and kidney. This indicates that lack of pyridoxine affects the metabolism of phenylbutazone and amino pyrine. The magnitude of reduction in the metabolism of these drugs was found to be greater when pyridoxine deficiency was produced in rats receiving a protein-deficient (8% casein) diet. This might be ascribed to a greater depletion of pyridoxine in deoxy pyridoxine-ingested rats receiving a protein deficient diet. The diminished activities of phenylbutazone oxidase and aminopyrine N-demethylase in deoxypyridoxine-ingested rats were not accompanied by a decreased activity of NADPH oxidase. This indicates that the effect of lack of pyridoxine on phenylbutazone oxidase and aminopyrine N demethylase activities was not mediated through influence on NADPH oxidase activity.
Thyroxine has been known to influence the activity of certain drug-metabolizing enzymes (32-35), but the present investigation revealed that thyroxine supplementation to deoxypyridoxine-ingested rats failed to reverse the change in phenylbutazone oxidase and aminopyrine N-demethylase activities. This suggests that the deficiency of thyroid hormone could not be implicated for the decreased activity of phenylbutazone oxidase and aminopyrine N-demethylase in pyridoxine deficiency as produced by ingestion of deoxypyridoxine.
It is, therefore, possible that pyridoxine in the form of pyridoxal phosphate might be involved in one or more of the steps of enzymatic reactions involving metabolism of phenylbutazone and aminopyrine. The possible involvement of pyridoxal phosphate-dependent enzymes in the me tabolism of diphenylhydantoin and pheno barbital, as suggested by Hansson and Sillanpaa (36), might bear a relevance to the present study.
